Clinical trial

The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking…

NCT00189618 · Arteriogenesis Competence Network, Other · Completed

Key facts

NCT number NCT00189618
Title The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
Official title The Effects of Physical Training, Aspirin, and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease
Lead sponsor Arteriogenesis Competence Network, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Peripheral Arterial Disease
Intervention type Drug
Interventions Aspirin, Clopidogrel
Enrollment 250
Start date May 1, 2005
Primary completion Apr 1, 2008
Completion Jun 1, 2008
First posted Sep 19, 2005
Last update posted Oct 6, 2008
Countries Germany, Switzerland

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies